News
-
-
-
-
-
-
-
-
-
PRESS RELEASE
The Impact of the VenoValve(R) on Patients with Primary and Secondary Chronic Venous Insufficiency (CVI) to be Presented at the Society for Clinical Vascular Surgery 52nd Annual Symposium
enVVeno Medical Corporation to present abstract on VenoValve for venous disease treatment at SCVS Symposium. Potential FDA decision in 2025. CVI impact and Company overview -